Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Posted on April 30th, 2021 by Ann-Marie RocheChemistry
The insights only found in patents can provide a crucial competitive advantage for innovative companies. In response to customer demand, Elsevier recently announced a major expansion of the patent content available to users of Reaxys, our chemistry information solution. Users can now get relevant patents for pharma and chemical R&D from 105 patent offices and 170 IPC classes. This also includes English language translations of foreign-language patents, which is important given that scientific advances are being made every day all across the globe.(more…)
Posted on April 26th, 2021 by Tom WilliamsMedical Information
Part 3: What phactMI provides to the healthcare community
As explained in the first two posts in this series (read Part 1 and Part 2), robust scientific and clinical information about medicinal products is an essential resource for healthcare professionals. However, access to this information has not always been easy.(more…)
Posted on April 20th, 2021 by Ann-Marie RocheChemistry
The Reaxys PhD Prize is a global competition that recognizes accomplished young chemists for their innovative research. The only requirements to participate are that one must be in the process of completing a PhD, or recently have completed one – and it can be in any discipline of chemistry.
For 10 years now, Elsevier has been proud to promote exciting research from early-career scientists through this competition (read about the 10th anniversary symposium) and is also honored to be able to help them do this important work through the use of tools like Reaxys.(more…)
Posted on April 15th, 2021 by Lauren BarhamAI & Data
Biocurators are among the unsung heroes of the life sciences world, performing the essential task of translating and integrating biomedical information into interoperable databases. Of course, there is a lot more to it than that, as attendees of the International Society for Biocuration’s 14th Annual Biocuration Conference already know.(more…)
Posted on April 13th, 2021 by Ann-Marie RocheChemistry
If there is one thing we at Elsevier have learned over the last 10 years of hosting the Reaxys PhD Prize, it’s that there are many different paths to research success. We have seen incredible work from scientists coming from a variety of backgrounds and experiences, and that was again evident with our three winning finalists for the 2020 Reaxys PhD Prize.(more…)
Posted on April 7th, 2021 by Heather Desmarais, MLSPharma R&D
Scientific literature is a critical component to virtually all aspects of a life science enterprise, including Medical Affairs, Pharmacovigilance and R&D. However, the process of curating and sharing literature can lead to significant challenges in organizing content, facilitating collaboration and enforcing copyright compliance.(more…)
About this Blog
The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.
Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier, its affiliates and sponsors or its parent company, Reed Elsevier.